RECCE 327 developed by Recce Pharmaceuticals Ltd (ASX:RCE) has destroyed every bacterium it has been tested against, including superbugs, and has proved invulnerable to any attempt by bacteria to ...
Recce Pharmaceuticals Ltd, a global company developing a new class of synthetic anti-infectives, has announced positive data from a phase II clinical trial evaluating RECCE 327 topical gel (R327G) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback